Epocrates Company Profile (NASDAQ:EPOC)

About Epocrates (NASDAQ:EPOC)

Epocrates logoEpocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:EPOC
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Dividend:
  • Dividend Yield: 1.0%
 
Frequently Asked Questions for Epocrates (NASDAQ:EPOC)

What is Epocrates' stock symbol?

Epocrates trades on the NASDAQ under the ticker symbol "EPOC."

Who are some of Epocrates' key competitors?

How do I buy Epocrates stock?

Shares of Epocrates can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Epocrates' stock price today?

One share of Epocrates stock can currently be purchased for approximately $11.73.


MarketBeat Community Rating for Epocrates (NASDAQ EPOC)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  59
MarketBeat's community ratings are surveys of what our community members think about Epocrates and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Epocrates (NASDAQ:EPOC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Epocrates (NASDAQ:EPOC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Epocrates (NASDAQ:EPOC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Epocrates (NASDAQ:EPOC)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Epocrates (NASDAQ:EPOC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Epocrates (NASDAQ:EPOC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Epocrates (NASDAQ:EPOC)
Latest Headlines for Epocrates (NASDAQ:EPOC)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

Chart

Epocrates (EPOC) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff